The new HCPCS Level II code for “Injection, tocilizumab-aazg (Tyenne), biosimilar, 1 mg” is Q5135. “These CMS designations are important reimbursement milestones for Tyenne because they ease access ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that the Centers for Medicare and Medicaid Services (CMS) issued a permanent, product-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results